Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3008461619.
Observations7
Issue DateApril 28, 2017
Status2 Related Warning Letters
Establishment TypeHuman Drug Manufacturer
Related Inspections7
Establishment Details
Firm
Eugia Pharma Specialities Limited
Issued To
Aurobindo Pharma Ltd. Unit IV
Location
Pashamylaram, -, India
FEI Number
3008461619
Establishment Type
Human Drug Manufacturer
Product Type
Drugs
Issue Date
April 28, 2017
Country
India
Inspection History, 2012 to 2026
NAI1
VAI4
OAI2
NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.
Talk to a Specialist